The boom of Sildenafil initially drove significant progress in the pharmaceutical sector, producing a perception of substantial profits. However, placing capital in companies heavily reliant on flagship drugs like https://rajannjsm433913.post-blogs.com/61946754/the-blue-pill-and-big-pharma-a-risky-bet